BEIRUT, LEBANON (10:40 P.M.) – Havana announced that it has signed an agreement with Tehran to transfer technology related to its most advanced potential vaccines against the coronavirus and to conduct the last phase of its clinical trials in Iran.
The Finlay Vaccine Institute in Cuba said late on Friday that it had signed an agreement with Iran’s Pasteur Institute to cooperate in the “Superana 2” test.
The Finlay Institute said through its Twitter account: “This synergy will enable the two countries to advance more quickly with regard to vaccination against SARS-Cove-2.”
The Iranian media quoted a spokesman for the Ministry of Health, Kianoush Jahanpour, as saying that 50,000 volunteers will participate in conducting the third phase of clinical trials.
Jahanpour added that technology transfer and co-production are prerequisites for allowing human testing to be carried out in the country.
The two allies, Cuba and Iran, are subject to strict US sanctions that exclude drugs, but which often prevent foreign pharmaceutical companies from trading with them. Consequently, the two countries seek self-reliance while suffering jointly from a lack of liquidity.
Cuba says that several countries have expressed interest in coronavirus vaccines, but this is the first agreement of its kind reached.